To discuss the relationship between drug rehabilitation motivation and mental health of drug addicts. The Motivation for Drug Rehabilitation Scale for Compulsory Drug Rehabilitation and the Self-Reported Health Measurement Scale (SRHMS) were chosen to measure 99 drug rehabilitation patients in a drug rehabilitation center, and 98 valid questionnaires were obtained. Drug rehabilitation motivation differed in terms of occupation (P<0.05), and the motivation of self-employed mandatory drug rehabilitants was higher than that of those who were unemployed. Mental health differed in work situation (P<0.05), and the mental health of drug addicts with work was higher than that of drug addicts without work. (iii) Motivation for drug rehabilitation was significantly correlated with SRHMS (P<0.01); sub-dimensions remorsefulness, cognitive adjustment, external boosting, and conviction were significantly correlated with SRHMS (P<0.01), and external boosting was correlated with SRHMS (P<0.05). There is a correlation between motivation and mental health among drug addicts, and cognitive adjustment and conviction have a positive predictive effect on mental health.

Su Lie, Zhu Yunpeng, Ren Hong. The Relationship between Motivation and Mental Health among Drug Addicts in Recovery. Academic Journal of Medicine & Health Sciences (2024), Vol. 5, Issue 7: 21-27. https://doi.org/10.25236/AJMHS.2024.050704.

[1] Opsal, A., Kristensen, Ø., & Clausen, T. (2019). Readiness to change among involuntarily and voluntarily admitted patients with substance use disorders. Substance Abuse Treatment, Prevention, and Policy, 14(1), 47. 

[2] Ali, B., Green, K. M., Daughters, S. B., & Lejuez, C. W. (2017). Distress tolerance interacts with circumstances, motivation, and readiness to predict substance abuse treatment retention. Addictive Behaviors, 73, 99–104.

[3] Greiner, M. G., Shulman, M., Choo, T. H., Scodes, J., Pavlicova, M., Campbell, A. N. C., Novo, P., Fishman, M., Lee, J. D., Rotrosen, J., & Nunes, E. V. (2021). Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapse. Journal of Substance Abuse Treatment, 131, 108447.

[4] Brothers, S., Viera, A., & Heimer, R. (2021). Changes in methadone program practices and fatal methadone overdose rates in Connecticut during COVID-19. Journal of Substance Abuse Treatment, 131, 108449.

[5] Coupland, H., Moensted, M. L., Reid, S., White, B., Eastwood, J., Haber, P., & Day, C. (2021). Developing a model of care for substance use in pregnancy and parenting services, Sydney, Australia: Service provider perspectives. Journal of Substance Abuse Treatment, 131, 108420.